全文获取类型
收费全文 | 42998篇 |
免费 | 3009篇 |
国内免费 | 148篇 |
专业分类
耳鼻咽喉 | 465篇 |
儿科学 | 1377篇 |
妇产科学 | 1175篇 |
基础医学 | 5915篇 |
口腔科学 | 493篇 |
临床医学 | 6271篇 |
内科学 | 8237篇 |
皮肤病学 | 712篇 |
神经病学 | 4352篇 |
特种医学 | 812篇 |
外国民族医学 | 1篇 |
外科学 | 3479篇 |
综合类 | 763篇 |
一般理论 | 42篇 |
预防医学 | 5009篇 |
眼科学 | 882篇 |
药学 | 2988篇 |
中国医学 | 79篇 |
肿瘤学 | 3103篇 |
出版年
2023年 | 223篇 |
2022年 | 469篇 |
2021年 | 863篇 |
2020年 | 478篇 |
2019年 | 799篇 |
2018年 | 931篇 |
2017年 | 721篇 |
2016年 | 804篇 |
2015年 | 976篇 |
2014年 | 1309篇 |
2013年 | 1990篇 |
2012年 | 3012篇 |
2011年 | 3166篇 |
2010年 | 1603篇 |
2009年 | 1557篇 |
2008年 | 2844篇 |
2007年 | 3064篇 |
2006年 | 3146篇 |
2005年 | 3098篇 |
2004年 | 3010篇 |
2003年 | 2824篇 |
2002年 | 2617篇 |
2001年 | 377篇 |
2000年 | 273篇 |
1999年 | 373篇 |
1998年 | 483篇 |
1997年 | 417篇 |
1996年 | 378篇 |
1995年 | 361篇 |
1994年 | 267篇 |
1993年 | 297篇 |
1992年 | 206篇 |
1991年 | 205篇 |
1990年 | 186篇 |
1989年 | 179篇 |
1988年 | 194篇 |
1987年 | 152篇 |
1986年 | 131篇 |
1985年 | 153篇 |
1984年 | 191篇 |
1983年 | 185篇 |
1982年 | 237篇 |
1981年 | 176篇 |
1980年 | 184篇 |
1979年 | 110篇 |
1978年 | 107篇 |
1977年 | 112篇 |
1976年 | 86篇 |
1975年 | 71篇 |
1974年 | 78篇 |
排序方式: 共有10000条查询结果,搜索用时 12 毫秒
991.
992.
993.
994.
995.
Stanley J. Kandzari Dale Riggs Barbara Jackson Adam Luchey Claire Oliver Stanley Zaslau 《Current Urology》2013,6(4):199-204
Background
Inositol Hexaphosphate (IP6) is a naturally occurring polyphosphorylated carbohydrate that is found in food sources high in fiber content. We hypothesized that IP6 would inhibit the cell growth rate of bladder cancer in vitro.Methods
T24 and TCCSUP bladder cancer cell lines were treated with titrating doses of IP6 (0.3, 0.6 and 0.9 mM/well). Cell viability and vascular endothelial growth factor levels were measured.Results
Significant reductions (p < 0.001) in cellular growth were noted in both cell lines at all doses and time points tested, with the exception of 0.3 mM IP6 at 24 hours in the T24 cell line. The percent inhibition of vascular endothelial growth factor was significantly higher than that observed in the TCCSUP cell line at 48 and 72 hours with 0.3 mM IP6 (p < 0.001). The T24 cells exhibited the same level of inhibition at 24 and 48 hours with 0.6 mM dose of IP6 and at 72 hours with the 0.3 mM dose (p < 0.001).Conclusions
In vitro treatment of bladder cancer with the common dietary polyphosphorylated carbohydrate IP6 significantly decreased cellular growth by anti-angiogenic mechanisms. We feel that this data warrants further investigation and consideration for initiation of clinical trials to evaluate the safety and clinical utility of this agent.Key Words: Cellular anti-proliferation, Bladder cancer, Angiogenesis, Inositol hexaphosphate, Vascular endothelial growth factor 相似文献996.
Donna L. Berry Barbara Halpenny Fangxin Hong Seth Wolpin William B. Lober Kenneth J. Russell William J. Ellis Usha Govindarajulu Jaclyn Bosco B. Joyce Davison Gerald Bennett Martha K. Terris Andrea Barsevick Daniel W. Lin Claire C. Yang Greg Swanson 《Urologic oncology》2013,31(7):1012-1021
ObjectiveThe purpose of this trial was to compare usual patient education plus the Internet-based Personal Patient Profile-Prostate, vs. usual education alone, on conflict associated with decision making, plus explore time-to-treatment, and treatment choice.MethodsA randomized, multi-center clinical trial was conducted with measures at baseline, 1-, and 6 months. Men with newly diagnosed localized prostate cancer (CaP) who sought consultation at urology, radiation oncology, or multi-disciplinary clinics in 4 geographically-distinct American cities were recruited. Intervention group participants used the Personal Patient Profile-Prostate, a decision support system comprised of customized text and video coaching regarding potential outcomes, influential factors, and communication with care providers. The primary outcome, patient-reported decisional conflict, was evaluated over time using generalized estimating equations to fit generalized linear models. Additional outcomes, time-to-treatment, treatment choice, and program acceptability/usefulness, were explored.ResultsA total of 494 eligible men were randomized (266 intervention; 228 control). The intervention reduced adjusted decisional conflict over time compared with the control group, for the uncertainty score (estimate ?3.61; (confidence interval, ?7.01, 0.22), and values clarity (estimate ?3.57; confidence interval (?5.85,?1.30). Borderline effect was seen for the total decisional conflict score (estimate ?1.75; confidence interval (?3.61,0.11). Time-to-treatment was comparable between groups, while undecided men in the intervention group chose brachytherapy more often than in the control group. Acceptability and usefulness were highly rated.ConclusionThe Personal Patient Profile-Prostate is the first intervention to significantly reduce decisional conflict in a multi-center trial of American men with newly diagnosed localized CaP. Our findings support efficacy of P3P for addressing decision uncertainty and facilitating patient selection of a CaP treatment that is consistent with the patient values and preferences. 相似文献
997.
Paul A. Toste Brian E. Kadera Sergei F. Tatishchev David W. Dawson Barbara M. Clerkin Raman Muthusamy Rabindra Watson James S. Tomlinson Oscar J. Hines Howard A. Reber Timothy R. Donahue 《Journal of gastrointestinal surgery》2013,17(12):2105-2113
Background
The optimal surgical management of small nonfunctional pancreatic neuroendocrine tumors (NF-PNETs) remains controversial. We sought to identify (1) clinicopathologic factors associated with survival in NF-PNETs and (2) preoperative tumor characteristics that can be used to determine which lesions require resection and lymph node (LN) harvest.Methods
The records of all 116 patients who underwent resection for NF-PNETs between 1989 and 2012 were reviewed retrospectively. Preoperative factors, operative data, pathology, surgical morbidity, and survival were analyzed.Results
The overall 5- and 10-year survival rates were 83.9 and 72.8 %, respectively. Negative LNs (p?=?0.005), G1 or G2 histology (p?=?0.033), and age <60 years (p?=?0.002) correlated with better survival on multivariate analysis. The 10-year survival rate was 86.6 % for LN-negative patients (n?=?73) and 34.1 % for LN-positive patients (n?=?32). Tumor size ≥2 cm on preoperative imaging predicted nodal positivity with a sensitivity of 93.8 %. Positive LNs were found in 38.5 % of tumors ≥2 cm compared to only 7.4 % of tumors <2 cm.Conclusions
LN status, a marker of systemic disease, was a highly significant predictor of survival in this series. Tumor size on preoperative imaging was predictive of nodal disease. Thus, it is reasonable to consider parenchyma-sparing resection or even close observation for NF-PNETs <2 cm. 相似文献998.
Filip Bednar James M. Scheiman Barbara J. McKenna Diane M. Simeone 《Journal of gastrointestinal surgery》2013,17(10):1826-1831
Introduction
The pancreas can serve as the destination for metastatic spread of malignancies from multiple organ sites. Breast cancer metastases to the pancreas are part of this spectrum and surgeons evaluate such patients as part of their practice. Uniform clinical guidelines for these cases do not exist and care is primarily driven by the personal experience of the treating surgeon.Discussion
We present two patients with breast cancer metastases to their pancreas and review their workup and clinical management in light of our experience and the existing published literature. We propose that metastatic disease to the pancreas has to remain in the differential diagnosis for any patient with a new pancreatic mass and prior cancer history. Surgical resection is a viable treatment option for patients with isolated metastatic disease to the pancreas if the underlying biology of the metastatic tumor is favorable. 相似文献999.
Peter Panhofer Christopher Springer Barbara Izay Matthäus Grasl Martin Burian Sebastian F. Schoppmann Thomas Rath Raimund Jakesz Johannes Zacherl 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》2013,398(2):221-230
Purpose
Squamous cell cancer (SCC) of the pharyngoesophageal junction area has a poor prognosis mainly due to late symptom manifestation and diagnosis. Treatment of choice is still pharyngolaryngoesophagectomy, substantially affecting quality of life. Limited surgical procedures have been adopted as well. The aim of this retrospective study was to evaluate whether the extent of resection influences postoperative safety and mortality.Methods
From 1984 to 2006, 66 patients were operated at a single tertiary referral center. Nineteen patients (28.8 %) had SCC of the hypopharynx and 47 patients (71.2 %) had SCC of the cervical and cervicothoracic esophagus. Thirty-five patients (53.0 %) underwent cervical esophageal resection (CE) and 31 underwent total esophagectomy (TE). In 39 patients (59.1 %), the larynx was preserved. Thirteen patients (19.7 %) underwent multimodal treatment.Results
Overall postoperative morbidity was 69.7 % and reoperation rate reached 28.8 %. TE (P?=?0.03) and larynx preservation (P?=?0.02) were followed by a higher rate of non-lung infections compared with CE and pharyngolaryngectomy, respectively. Pulmonary complications have been observed more frequently after larynx preservation (P?=?0.02). Hospital mortality was 9.1 %. Four patients died after TE (12.9 %) and two patients died after CE (5.7 %). In all of them, the larynx had been preserved (15.4 %). Overall, 53 patients (80.3 %) died until follow-up. One-year and 5-year survival in patients with the major tumor burden at the cervicothoracic site was 35.7 and 0 %.Conclusions
CE can be recommended as long as R0 resection is warranted. The advantage of larynx preservation is gained by higher morbidity and mortality rates and may not be recommended as standard procedure. Surgery may not be appropriate for advanced SCC in the cervicothoracic region. 相似文献1000.